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Through tissue imaging of a live breast cancer
tumour model using handheld surface enhanced
spatially oﬀset resonance Raman spectroscopy
(SESORRS)†
Fay Nicolson, a Lauren E. Jamieson, a Samuel Mabbott, a
Konstantinos Plakas, b Neil C. Shand, c Michael R. Detty, b Duncan Graham a
and Karen Faulds *a
In order to improve patient survival and reduce the amount of unnecessary and traumatic biopsies, non-
invasive detection of cancerous tumours is of imperative and urgent need. Multicellular tumour
spheroids (MTS) can be used as an ex vivo cancer tumour model, to model in vivo nanoparticle (NP)
uptake by the enhanced permeability and retention (EPR) eﬀect. Surface enhanced spatially oﬀset Raman
spectroscopy (SESORS) combines both surface enhanced Raman spectroscopy (SERS) and spatially oﬀset
Raman spectroscopy (SORS) to yield enhanced Raman signals at much greater sub-surface levels. By
utilizing a reporter that has an electronic transition in resonance with the laser frequency, surface
enhanced resonance Raman scattering (SERRS) yields even greater enhancement in Raman signal. Using
a handheld SORS spectrometer with back scattering optics, we demonstrate the detection of live breast
cancer 3D MTS containing SERRS active NPs through 15 mm of porcine tissue. False color 2D heat
intensity maps were used to determine tumour model location. In addition, we demonstrate the tracking
of SERRS-active NPs through porcine tissue to depths of up to 25 mm. This unprecedented performance
is due to the use of red-shifted chalcogenpyrylium-based Raman reporters to demonstrate the novel
technique of surface enhanced spatially oﬀset resonance Raman spectroscopy (SESORRS) for the ﬁrst
time. Our results demonstrate a signiﬁcant step forward in the ability to detect vibrational ﬁngerprints
from a tumour model at depth through tissue. Such an approach oﬀers signiﬁcant promise for the
translation of NPs into clinical applications for non-invasive disease diagnostics based on this new
chemical principle of measurement.
Introduction
Non-invasive tumour detection is of vital importance for early
cancer diagnosis, resulting in improved patient survival.
Multicellular tumour spheroids (MTS) are used as tumour
models and mimic in vivo tumour physiology. In contrast to
traditional 2D monolayer cell cultures, these three dimensional
cell models resemble the 3D in vivo environment more closely,
establishing characteristic concentration gradients in oxygen,
nutrients, and metabolites.1 MTS can be used as an ex vivo
cancer model, avoiding the need for ethical approval and long
term experiments associated with in vivo experiments. Termed
the enhanced permeability and retention (EPR) eﬀect, tumours
retain nanoparticles (NPs) in their microenvironments due to
poor lymphatic drainage. Thus, NP uptake is preferential in
cancerous cells over healthy cell lines and NPs are frequently
used to assist in imaging applications.2 MTS can be grown with
a uniform distribution of NPs dispersed throughout and can
provide a model for NP accumulation in tumours in vivo.3 MTS
models were used here to develop a Raman imaging technique
for eﬀective tumour detection though tissue depths of several
millimeters.
Raman spectroscopy has previously been investigated for
tumour detection,4 but is oen limited to biopsy and cellular
samples making it unable to non-invasively detect tumours at
depth. Spatially oﬀset Raman spectroscopy (SORS) provides
ameans of non-invasive investigation of tissue samples at depth
by oﬀsetting the point of collection from the point of laser
excitation typically in the region of a few mm (Dx).5,6 Unlike
confocal techniques where spectral information can be
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acquired at a particular depth by focusing the laser to a given
distance in the z-axis, SORS makes use of a spatial oﬀset to
probe through the barrier/analyte system.5 SORS has shown
promise in a number of applications including the detection of
counterfeit alcohol,7 assessment of bone composition8,9 and in
the analysis of cancerous calcications in breast tissue.4 We
have recently reported the use of a handheld SORS spectrometer
for the detection of ethanol through up to 21 mm of plastic.10
When a molecule is adsorbed onto a metal NP surface,
enhancement in scattering of the molecularly specic Raman
reporter is observed. The surface enhanced Raman scattering
(SERS) approach has been shown to yield enhancements several
orders of magnitude greater than conventional Raman scat-
tering.11 SERS has been applied in numerous applications
including the sensitive detection of DNA,12 explosives detec-
tion,13 and in drug delivery sensing.14 Furthermore, through
surface enhanced resonance Raman spectroscopy (SERRS), it is
possible to greatly increase the Raman signal generated by the
nanotags by using a laser that corresponds to an electronic
transition of the Raman analyte to produce enhancements in
the order of 1010 to 1014.15,16
Surface enhanced spatially oﬀset Raman spectroscopy
(SESORS) combines the benets of SORS with SERS to achieve
greater sample interrogation at depth.17 Using SESORS in a 180
back-scattering conguration, nanotags have been used in
glucose sensing,18 tracked through 6.75 mm of tissue,19 and up
to 8 mm of bone.20,21 Using SESORS in a transmission geometry,
bisphosphonates have been tracked in bone through 20 mm of
tissue22 and Stone et al. detected signal from nanotags through
45–50 mm of tissue.17 Several reports in the literature show the
potential to target and image tumours in vivo using function-
alized NPs.23,24 Kircher et al., functionalised Au nanoprobes with
chalcogenpyrylium based dyes and the EGFR targeting antibody
to successfully detect tumours in vivo using a mouse model.25
Whilst the authors reported attomolar limits of detection, little
knowledge exists on the ability to detect tumours at clinically
signicant and relevant depths, and therefore the approach
presented here provides a model to image and thus demon-
strate, NP uptake in cancerous cells at notable depth. Here we
report for the rst time the use of NPs for the detection of a 3D
breast tumour model buried at depths of 15 mm in tissue using
a SORS instrument with back scattering optics. This was ach-
ieved by growing 3D breast cancer tumour models from cells
incubated with SERRS active gold NPs (AuNPs) and then using
the signal enhancing benets of SERRS, combined with the
through barrier detection capabilities of SORS, to locate the
tumour model at depth using surface enhanced spatially oﬀset
resonance Raman spectroscopy (SESORRS) for the rst time. In
addition, these SESORRS measurements were carried out using
a handheld spectrometer, which could potentially be used in
a clinical environment. Furthermore, using the SESORRS
approach, we report a penetration depth of up to 25 mm
through tissue; the largest thickness to which SERS nanotags
have been tracked using a back-scattering conguration.
To achieve the detection of the tumour model at depth using
the accumulation of NPs within a live 3D tumour model, we
used chalcogenpyrylium dyes as resonant Raman reporters in
combination with SESORRS detection. The absorbance wave-
length of chalcogenpyrylium dyes can be ne-tuned into the
near-infrared (NIR) to create a Raman reporter in resonance
with the laser excitation wavelength of 830 nm.25 Our previous
work has explored the use of red-shied nanomaterials as SERS
probes in the NIR by utilizing large AuNPs in conjunction with
chalcogenpyrylium nanotags.26 Chalcogenpyrylium dyes conju-
gated to large AuNPs have been shown to generate strong SERS
responses at picomolar detection levels at 1280 nm 27 and
1550 nm laser excitations.26 The chemical structure of each of
the ve Raman reporters used are shown in Fig. 1a–e. The
absorbance wavelengths of the highly Raman active chalco-
genpyrylium dyes; 676, 823, 959 (Fig. 1a–c), are tuned by
increasing the number of sp2 carbons from 1 to 3 to 5 in the
aliphatic backbone, thus, the wavelength of absorption is tuned
to 676, 823 and 959 nm respectively.26,27 Further ne tuning is
achieved through the choice of chalcogen atoms in the ring
systems, which causes the absorption maximum to redshi.
BPE (d) and AZPY (e) are non-resonant small molecules
commonly used for SERS which were used for comparison.
SERS spectra for each of these ve Raman reporters are shown
in the ESI Fig. S2.† All measurements were carried out using
AuNPs with an average diameter of 83 nm. Each of the ve
Raman reporters were added to AuNPs to create nanotag solu-
tions with a nal dye concentration of 300 nM. The aim was to
keep the dye concentration as low as possible by exploiting the
benet of using a Raman reporter that is in resonance with the
laser. With regards to the experimental set up, all measure-
ments were carried out using a total exposure time of 10
seconds (2 s integration time, 5 accumulations) at an 8 mm
oﬀset. The nose cone was tted to use the instrument in
a contact mode setting. The handheld instrument used here has
a xed maximum exposure time, therefore it is noted that if
longer acquisition times were used, the signal to noise ratio may
have improved.
To investigate the advantage of using resonant molecules for
in vivo applications, nanotag solutions with each reporter were
held in a quartz microcuvette. Porcine tissue samples of a 5 mm
thickness were placed in front of the cuvette and brought into
contact with the laser leaving no space between the nose cone
and the sample (ESI, Fig. S3†). Spectra were acquired at an
8 mm spatial oﬀset and truncated and baselined prior to pro-
cessing. We have previously shown that at an 8 mm oﬀset, the
greatest level of through barrier detection takes place, which is
the maximum capability of the instrument.10 The height of the
most intense peak was then calculated as well as the relative
percentage peak intensity (Fig. 1f). The handheld SORS instru-
ment uses an excitation wavelength of 830 nm and it can be
seen clearly in Fig. 1f that a signicant enhancement in signal is
generated by the resonant dye 823 compared to the oﬀ resonant
molecules. Thus, by using a NIR resonant reporter molecule,
superior SERRS signal through depth is generated over oﬀ
resonant reporter molecules and the technique of SESORRS for
greater through tissue detection is clearly demonstrated.
MTS were used as a 3D breast cancer tumour model to
demonstrate the clinical signicance of SESORRS for in vivo
diagnostics. MCF7 human breast cancer cells were incubated
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 3788–3792 | 3789





























































































overnight with the dye 823 nanotag solution (571 fM of AuNps,
total of 7.092  1011 AuNp) resulting in uptake and accumula-
tion of the nanotags within the cancer cells. MTS were then
grown from a suspension of these cells using a hanging drop
technique by pipetting 20 mL drops of MCF7 human breast
cancer cell suspension onto the lid of a Petri dish. They were
grown over a period of 9 days at 37 C and 5% CO2 in
a humidied incubator to a size <1 mm. No reduction in growth
was observed. It is therefore reasonable to assume that the dyes
did not cause cell death since cells need to be alive in order to
divide and replicate to formMTSmodels. Previous reports show
that NPs are homogenously dispersed throughout the MTS.3
As described in Fig. S4, ESI,† roughly 10 MTS were trans-
ferred to a section of tissue (a). A 15 mm section of porcine
tissue was then placed on top of the tissue layer upon which the
MTS models were positioned (b). This model simulated the
detection of SERRS active nanotags in tumours through tissue
using the SORS approach. A translational x–y stage with a range
of 2.54 cm was used to maneuver the tissue samples in steps of
3 mm to create an image of 7 7 pixels. As per the experimental
set up described in Fig. S4, ESI,† the tissue system was brought
into contact with the nose cone, and the z-value remained xed,
i.e. the stage was not moved in the z-direction. By xing the
z-direction, and utilising the SORS technique, we were able to
probe through the tissue barrier to detect the MTS models
through 15mm of tissue. This was achieved bymoving the stage
the x–y direction to detect the MTS models through the tissue
barrier. A false colour 2D SESORRS heat map of the peak
intensity at 1178 cm1 was then constructed, Fig. 2a. This
corresponds to the uptake of dye 823 nanotags into MTS. Clear
discrimination is seen between areas where the MTS were
present and where they were not (Fig. 2a, b). There is a direct
correlation between where the MTS models containing the
SERRS-active nanotags were placed and the observed area of
maximum intensity on the 2D map, i.e. the area of maximum
intensity corresponds to the region in which the MTS models
were positioned, (Fig. S4, ESI†). Similarly, at the point of
minimum intensity in areas where the MTS models were not
present, there was no spectral contribution from the dye
(Fig. 2b). In this instance, the observed spectrum corresponds
to that of the tissue. Therefore, since we know the precise
location of the spheroids in the tissue, control spectra can be
generated on the same image but away from theMTS deposition
point. Furthermore, the SERRS-active NPs were contained
within the spheroids themselves and therefore their location
within in the system was known prior to imaging. The number
of NPs present in eachMTS was signicantly less than for a bulk
sample i.e. a nanotag solution held in a cuvette. However,
despite this, the extremely sensitive detection of both dye
823 peaks at 1178 and 1592 cm1 is conrmed in areas where
the nanotags, and hence spheroid tumour models, were present
(Fig. 2b), and thus the successful mapping of MTS through
15 mm of tissue using SESORRS was achieved. This proof of
concept experiment demonstrates that targeted NPs in combi-
nation with SESORRS imaging could potentially be used to
locate tumours at depth in vivo.
In a secondary, but no less signicant demonstration of the
power of this approach, dye 823 SERRS-active nanotags were
detected through 25 mm of tissue. The nanotags were held in
a quartz microcuvette (ESI Fig. S3†) and placed behind 25 mm
of porcine tissue. Fig. 3 shows the dye 823 reference spectrum
and tissue reference spectrum (top and bottom). The middle
spectrum refers to SESORRS signal collected using an 8 mm
oﬀset. Both characteristic dye 823 peaks (1178 cm1 and
1592 cm1) are detectable by eye with the peak at 1178 cm1
having greater distinction due to the lack of spectral overlap
Fig. 1 (a–e) Chemical structure of dye 676, dye 823, dye 959, BPE and AZPY respectively. (f) Bar chart showing average peak intensities of dye
676, dye 823, dye 959, BPE and AZPY at 1598, 1592, 1572, 1201 and 1162 cm1 respectively, as well as the relative percentage peak intensity,
through 5 mm of tissue. Nanotag solutions were held in a cuvette and the cuvette was placed behind tissue samples. Spectra were collected
using a handheld SORS instrument with 830 nm laser excitation at an 8 mm oﬀset. Peak intensities were obtained by scanning 3 replicate
samples, 5 times (2 second integration, 5 accumulations). The average peak intensity for each of the 5 dyes is shown and error bars represent 
one standard deviation.
3790 | Chem. Sci., 2018, 9, 3788–3792 This journal is © The Royal Society of Chemistry 2018





























































































from the tissue in the 1600 cm1 region. A scaled subtraction
was also applied (Fig. S5, ESI†). This also conrms the detection
of dye 823 demonstrating impressive potential of the SESORRS
approach to detect nanotags through 25 mm of tissue using
a back-scattering conguration by controlling the SERRS eﬀect
to achieve superior depth penetration. In previous collabora-
tions with Stone and Matousek non-resonant SERS nanotags
were detected through depths of up to 25 and 50 mm, however
this was using a transmission geometry and a benchtop
instrument.17 The results detailed here report the largest
thickness that nanotags have been detected through using
a back-scattering optical approach. Furthermore, all previous
reports of SESORS has involved a benchtop system and this
work highlights the ability of a handheld instrument to detect
SESORRS signals through large thicknesses of tissue.
Through utilizing powerful chalcogenpyrylium-based Raman
reporters for SERRS applications in combination with SORS we
present the SESORRS technique for the rst time, made possible
through the resonant Raman tags, and report the highly signif-
icant and successful detection of 3D breast tumour models
through 15mmof tissue. To the best of our knowledge this is the
rst report of the detection of 3D tumour models using
SESORRS. Furthermore, we show it is possible to detect nano-
tags through up to 25 mm of tissue, which is the largest thick-
ness of through barrier detection reported using a back-
scattering geometry, in contrast to a transmission approach.
Previous work in the SESORS eld has also involved benchtop
systems, which are bulky and lack portability. The handheld
instrument used in this instance has a xed accumulation, i.e.
the instrument permits only a certain maximum exposure time.
Thus, whilst we would expect to achieve larger depth penetration
and improved signal to noise with high-end benchtop systems
which can facilitate longer acquisition times, particularly when
resonant reporter molecules are used, the results described here
show the excellent potential of handheld SORS which is more
suited to clinical applications. Through the exploitation of the
resonance eﬀect, this novel work represents a signicant step
forward in the detection of vibrational ngerprints through
tissue samples. Thus, an important step forward in the use of
handheld back-scattering SESORRS for potential clinical appli-
cations including non-invasive tumour detection is demon-
strated. Future work will focus on targeting and imaging
tumours in vivo using SESORRS through the use of dual
Fig. 2 (a) A false colour xy-2D heat SESORRSmap of MTS containing dye 823 through 15mm of tissue. Themap was constructed using the peak
intensity at 1178 cm1. Measurements were carried out using an xy translational stage in step sizes of 3 mm to create an image of 7  7 pixels.
Spectra were truncated, baselined and smoothed prior to processing. A combination surface/contour false colour was used to generate a 2D
heat map and show the tracking of the MTS through 15 mm of tissue. Clear discrimination is seen between spectra collected at the point of
maximum intensity where the nanotags uptaken into MTS models were spotted, and that collected where the MTS were not present. (b) The
corresponding maximum and minimum collected 8 mm oﬀset spectra. All measurements were carried out using a 2 s integration time, 5
accumulations, 830 nm laser excitation wavelength.
Fig. 3 The tracking of dye 823 nanotag solution through 25 mm of
tissue. The tissue and dye 823 reference spectra are shown at the
bottom and top respectively. The middle spectrum represents the
Raman signal collected at an 8 mm oﬀset through 25 mm of tissue.
The peak at 1178 cm1 is easily detectable by eye and the peak at
1592 cm1 is also detectable, albeit to a lesser extent. All measure-
ments were carried out using a 2 s integration time, 5 accumulations,
830 nm laser excitation wavelength.
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 3788–3792 | 3791





























































































functionalised NPs, i.e. NPs functionalised with both a reporter
molecule and a biomolecule that specically targets the tumour
in vivo. The use of a Raman reporter molecule will then facilitate
the imaging of diseased tissue at depth due to accumulation of
biofunctionalised NPs at the tumour site. Investigation of
tumour depth location is also important and this will be inves-
tigated as the imaging capabilities of SORS develops to give
a better insight into tumour location in vivo.
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